Sustainable Cardiopulmonary Rehabilitation Services in the Home Act

This bill, S248, expands Medicare coverage for cardiopulmonary rehabilitation services delivered in a patient's home. This is happening now because there is a growing demand for convenient and accessible healthcare, especially for chronic conditions like heart and lung disease, and home-based care reduces facility overhead. The bill's referral to the Committee on Finance indicates it is moving through the legislative process, with potential for passage given the bipartisan appeal of cost-effective healthcare solutions. The money trail for this legislation flows directly from Medicare reimbursements to healthcare providers. Companies that offer home health services, particularly those with existing infrastructure for remote patient monitoring and in-home therapy, will see increased revenue. This includes large healthcare systems that operate home health divisions, specialized home health agencies, and potentially technology companies providing remote monitoring solutions. The bill does not appropriate new funds but rather reallocates existing Medicare spending to cover home-based services, expanding the addressable market for these services. Historically, similar legislation expanding Medicare coverage for home-based services has led to increased utilization and revenue for providers. For example, the expansion of telehealth coverage during the COVID-19 pandemic in 2020, while not identical, demonstrated a rapid shift to home-based care. Companies like Teladoc Health ($TDOC) saw their stock price surge over 100% in the first half of 2020 as telehealth adoption accelerated. While this bill is more specific, it follows a similar pattern of expanding reimbursement for care delivered outside traditional facilities. Another precedent is the 21st Century Cures Act in 2016, which promoted digital health and remote monitoring, leading to increased investment and adoption in these areas. Specific winners include large healthcare providers with significant home health divisions such as LabCorp ($LH) and HCA Healthcare ($HCA), which can expand their in-home rehabilitation offerings. Staffing companies like AMN Healthcare ($AMN), which supplies nurses and therapists, will see increased demand for home health professionals. Insurers like UnitedHealth Group ($UNH) and CVS Health ($CVS) (through Aetna and their home health initiatives) will benefit from potentially lower long-term costs associated with home-based care and can expand their service offerings. There are no direct losers, but facility-based rehabilitation centers may see a slight shift in patient volume towards home settings, though overall demand for rehabilitation remains high. The bill has been read twice and referred to the Committee on Finance. The next steps involve committee hearings, potential amendments, and a committee vote. If it passes the committee, it will move to the full Senate for a vote. A similar bill would need to pass the House of Representatives. Given its nature, it could be attached to a larger healthcare package or move as a standalone bill. A timeline for passage is typically 6-18 months from committee referral, but could be expedited if there is strong bipartisan support.